Healthequity (HQY) Cash from Investing Activities (2013 - 2026)

Healthequity's Cash from Investing Activities history runs 14 years deep, the most recent figure standing at -$13.9 million for Q2 2026.

• In Q2 2026, Cash from Investing Activities rose 13.87% year-over-year to -$13.9 million; the TTM figure through Apr 2026 stood at -$44.9 million (up 82.16% YoY), while the FY2026 annual figure was -$47.1 million, up 90.67% from the prior year.
• Cash from Investing Activities was -$13.9 million for Q2 2026 at Healthequity, down from -$8.4 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$8.4 million in Q1 2026 to a low of -$471.3 million in Q1 2022.
• Historically, Cash from Investing Activities has averaged -$66.8 million across 5 years, with a median of -$13.5 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities soared 97.82% in 2023, then slumped 2855.12% in 2024.
• A 5-year view of Cash from Investing Activities shows it stood at -$13.5 million in 2022, then slipped by 13.99% to -$15.4 million in 2023, then gained by 16.57% to -$12.9 million in 2024, then grew by 11.54% to -$11.4 million in 2025, then retreated by 22.17% to -$13.9 million in 2026.
• The last three Cash from Investing Activities figures came in at -$13.9 million (Q2 2026), -$8.4 million (Q1 2026), and -$11.4 million (Q4 2025), per Business Quant data.